Ziconotide is the first drug in its group, introduced in (the UK in) 2006. It is an N-type calcium channel blocker.
Licensed for intra-thecal injection. For chronic pain.
The original molecule is the venom of the sea-snail Conus magus. The drug is a synthesised peptide.